Sankesh Abbhi, Brand Insights Contributor, President and CEO of ArisGlobal
Advertisement
Articles by Sankesh Abbhi, Brand Insights Contributor, President and CEO of ArisGlobal
Advertisement
Latest Updated Articles
Advertisement
Advertisement
Trending on PharmExec
1
What Kinds of Disruption are GLP-1s Expected to Face
2
FDA Approves Datroway for Patients with Metastatic Triple-Negative Breast Cancer Who Are Not PD-1/PD-L1 Inhibitor Candidates
3
Eli Lilly and Novo Nordisk Shift Patients From Compounded Drugs to Lower-Cost Weight-Loss Pills: Report
4
The Evolving Relationship Between FDA and Biotech
5